Skip to main content
Clinical Trials/JPRN-UMIN000023431
JPRN-UMIN000023431
Completed
未知

A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep: randomized, placebo-controlled, double blind traial, cross-over study - A study for evaluating the effect of the combined intake of GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum on sleep

Pharma Foods International Co., Ltd.0 sites20 target enrollmentAugust 2, 2016
ConditionsHealthy adult

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adult
Sponsor
Pharma Foods International Co., Ltd.
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2016
End Date
January 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Subjects who routinely use food supplements or medicine containing GABA, extract of Hemerocallis fulva, and extract of Apocynum venetum. 2\) Subjects who take care for the improvement of mental fatigue, quality of sleep and stress. 3\) Subjects who have been diagnosed for and who are under any medical treatment. 4\) Subjects who have history of the medical treatment and who are under the medical treatment for diabetes, liver disease, kidney disease, or heart disease. 5\) Subjects who are planning to become pregnant and who are lactating. 6\) Subjects who are judged as unsuitable for the study by doctor for other reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials